Indee Labs focuses on the development of microfluidic vortex shedding for rapidly and efficiently transfecting human primary immune cells with negligible perturbation. The team is focused on developing its core technology for short turnaround chimeric antigen receptor T cell (CAR-T) development and manufacturing.
OverseasPhase FindingI SBIR
AusIndustryNational Institute for Allergy and Infectious Disease
Justin Jarrell, PhD
ScientistVice President, Research
CEOFounder, Chief Executive Officer